Geron to Present at Upcoming Investor Conferences in November
November 07 2018 - 4:30PM
Geron Corporation (Nasdaq: GERN) today announced that John A.
Scarlett, M.D., President and Chief Executive Officer, is scheduled
to present a company overview at the following investor
conferences:
- Stifel 2018 Healthcare Conference in New York at 2:00 p.m. ET
on Wednesday, November 14, 2018
- 30th Annual Piper Jaffray Healthcare Conference in New York at
11:30 a.m. ET on Tuesday, November 27, 2018
A live audio webcast of each presentation will be available on
Geron’s website, www.geron.com/investors/events. If you are unable
to listen to the live presentations, an archived webcast of each
presentation will be available on the Company’s website for 30
days.
About Geron
Geron is a clinical stage biopharmaceutical company focused on
the development and potential commercialization of a first-in-class
telomerase inhibitor, imetelstat, in hematologic myeloid
malignancies. For more information about Geron, visit
www.geron.com.
CONTACT:
Suzanne MessereInvestor and Media
Relationsinvestor@geron.commedia@geron.com
CG Capital877-889-1972
Geron (NASDAQ:GERN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Geron (NASDAQ:GERN)
Historical Stock Chart
From Apr 2023 to Apr 2024